Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Eleven Biotherapeutics
4371
Eleven Biotherapeutics
Health Care
Technology
Biotechnology
Eleven Biotherapeutics is focused on developing innovative protein-basedtherapeutics to improve human health and treat diseases.
Suggest edits
Founded
2010
Raised
$63M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Biogen
Xconomy
HubSpot
Money Mover
Formlabs
Akamai
General Catalyst
Companies in the same industry
Alder Biopharmaceuticals Inc. (Nasdaq: ALDR)
SuitX
Inotrem
Y-mAbs Therapeutics
Sensulin
Genenta Science
Contextual Genomics
Ezra
Ceribell
Optina Diagnostics
Alexa global traffic share
Overview
Funding
3
Acquisitions
1
Add info
Latest funding
Show all
$8,000,000
Post-IPO equity - 2017
$20,000,000
Post-IPO equity - 2014
Team Size
10+
Employees
I work here
Location
Cambridge
,
United States
Headquarters
Explore Cambridge
Acquisition
Seeking Alpha
,
businesswire
Eleven Biotherapeutics acquires Viventia Bio in all-stock deal
